Loading organizations...
§ Private Profile · Branford, CT, USA
Single-cell detection system for immune response assessment.
IsoPlexis has raised $193.8M across 5 funding rounds.
IsoPlexis has raised $193.8M in total across 5 funding rounds.
IsoPlexis has raised $193.8M in total across 5 funding rounds.
IsoPlexis's investors include Sam Chawla, Ally Bridge Group, BlackRock, Sharon Kedar, Christopher MacGriff, PhD, Connecticut Innovations, Ironwood Capital, North Sound Capital, North Sound Ventures, Matt Storeygard.
IsoPlexis has raised $193.8M across 5 funding rounds. Most recently, it raised $135.0M Debt / Series D in January 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 7, 2021 | $135M Debt Financing | SAM Chawla | Ally Bridge Group, BlackRock | Announced |
| Jan 9, 2020 | $20M Series C Plus | Sharon Kedar | — | Announced |
| May 14, 2019 | $25M Series C | Christopher Macgriff, PHD | Connecticut Innovations, Ironwood Capital, North Sound Capital | Announced |
| Sep 25, 2017 | $13.5M Series B | — | Connecticut Innovations, Ironwood Capital, North Sound Ventures | Announced |
| Aug 12, 2014 | $300K Venture Round | Matt Storeygard | — | Announced |